148 related articles for article (PubMed ID: 31521819)
21. Molecular genetics of the neuronal ceroid lipofuscinoses.
Mole S; Gardiner M
Epilepsia; 1999; 40 Suppl 3():29-32. PubMed ID: 10446748
[TBL] [Abstract][Full Text] [Related]
22. Molecular basis of the neuronal ceroid lipofuscinoses: mutations in CLN1, CLN2, CLN3, and CLN5.
Mole SE; Mitchison HM; Munroe PB
Hum Mutat; 1999; 14(3):199-215. PubMed ID: 10477428
[TBL] [Abstract][Full Text] [Related]
23. Batten's disease: clues to neuronal protein catabolism in lysosomes.
Dawson G; Cho S
J Neurosci Res; 2000 Apr; 60(2):133-40. PubMed ID: 10740217
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): Expert recommendations for early detection and laboratory diagnosis.
Fietz M; AlSayed M; Burke D; Cohen-Pfeffer J; Cooper JD; Dvořáková L; Giugliani R; Izzo E; Jahnová H; Lukacs Z; Mole SE; Noher de Halac I; Pearce DA; Poupetova H; Schulz A; Specchio N; Xin W; Miller N
Mol Genet Metab; 2016 Sep; 119(1-2):160-7. PubMed ID: 27553878
[TBL] [Abstract][Full Text] [Related]
25. The neuronal ceroid-lipofuscinoses: a historical introduction.
Haltia M; Goebel HH
Biochim Biophys Acta; 2013 Nov; 1832(11):1795-800. PubMed ID: 22959893
[TBL] [Abstract][Full Text] [Related]
26. Characterisation of early changes in ovine CLN5 and CLN6 Batten disease neural cultures for the rapid screening of therapeutics.
Best HL; Neverman NJ; Wicky HE; Mitchell NL; Leitch B; Hughes SM
Neurobiol Dis; 2017 Apr; 100():62-74. PubMed ID: 28065762
[TBL] [Abstract][Full Text] [Related]
27. Ocular Manifestations of Neuronal Ceroid Lipofuscinoses.
Singh RB; Gupta P; Kartik A; Farooqui N; Singhal S; Shergill S; Singh KP; Agarwal A
Semin Ophthalmol; 2021 Oct; 36(7):582-595. PubMed ID: 34106804
[TBL] [Abstract][Full Text] [Related]
28. The neuronal ceroid-lipofuscinoses (Batten disease): a new class of lysosomal storage diseases.
Bennett MJ; Hofmann SL
J Inherit Metab Dis; 1999 Jun; 22(4):535-44. PubMed ID: 10407785
[TBL] [Abstract][Full Text] [Related]
29. Applying modern Omic technologies to the Neuronal Ceroid Lipofuscinoses.
Kline RA; Wishart TM; Mills K; Heywood WE
Biochim Biophys Acta Mol Basis Dis; 2020 Sep; 1866(9):165498. PubMed ID: 31207290
[TBL] [Abstract][Full Text] [Related]
30. The neuronal ceroid-lipofuscinoses.
Haltia M
J Neuropathol Exp Neurol; 2003 Jan; 62(1):1-13. PubMed ID: 12528813
[TBL] [Abstract][Full Text] [Related]
31. NCLs and ER: A stressful relationship.
Marotta D; Tinelli E; Mole SE
Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1273-1281. PubMed ID: 28390949
[TBL] [Abstract][Full Text] [Related]
32. Current therapies for the soluble lysosomal forms of neuronal ceroid lipofuscinosis.
Wong AM; Rahim AA; Waddington SN; Cooper JD
Biochem Soc Trans; 2010 Dec; 38(6):1484-8. PubMed ID: 21118112
[TBL] [Abstract][Full Text] [Related]
33. Use of model organisms for the study of neuronal ceroid lipofuscinosis.
Bond M; Holthaus SM; Tammen I; Tear G; Russell C
Biochim Biophys Acta; 2013 Nov; 1832(11):1842-65. PubMed ID: 23338040
[TBL] [Abstract][Full Text] [Related]
34. Neuronal ceroid lipofuscinoses: classification and diagnosis.
Wisniewski KE; Kida E; Golabek AA; Kaczmarski W; Connell F; Zhong N
Adv Genet; 2001; 45():1-34. PubMed ID: 11332767
[TBL] [Abstract][Full Text] [Related]
35. Cln1 gene disruption in mice reveals a common pathogenic link between two of the most lethal childhood neurodegenerative lysosomal storage disorders.
Chandra G; Bagh MB; Peng S; Saha A; Sarkar C; Moralle M; Zhang Z; Mukherjee AB
Hum Mol Genet; 2015 Oct; 24(19):5416-32. PubMed ID: 26160911
[TBL] [Abstract][Full Text] [Related]
36. A CLN8 nonsense mutation in the whole genome sequence of a mixed breed dog with neuronal ceroid lipofuscinosis and Australian Shepherd ancestry.
Guo J; Johnson GS; Brown HA; Provencher ML; da Costa RC; Mhlanga-Mutangadura T; Taylor JF; Schnabel RD; O'Brien DP; Katz ML
Mol Genet Metab; 2014 Aug; 112(4):302-9. PubMed ID: 24953404
[TBL] [Abstract][Full Text] [Related]
37. Cellular pathology and pathogenic aspects of neuronal ceroid lipofuscinoses.
Kida E; Golabek AA; Wisniewski KE
Adv Genet; 2001; 45():35-68. PubMed ID: 11332776
[TBL] [Abstract][Full Text] [Related]
38. Progress towards understanding the neurobiology of Batten disease or neuronal ceroid lipofuscinosis.
Cooper JD
Curr Opin Neurol; 2003 Apr; 16(2):121-8. PubMed ID: 12644737
[TBL] [Abstract][Full Text] [Related]
39. You say lipofuscin, we say ceroid: defining autofluorescent storage material.
Seehafer SS; Pearce DA
Neurobiol Aging; 2006 Apr; 27(4):576-88. PubMed ID: 16455164
[TBL] [Abstract][Full Text] [Related]
40. Genetics of the neuronal ceroid lipofuscinoses (Batten disease).
Mole SE; Cotman SL
Biochim Biophys Acta; 2015 Oct; 1852(10 Pt B):2237-41. PubMed ID: 26026925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
